Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6XTP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $98,899
Award facts
- Contract value 100% obligated
- $98,898.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $98.9K on September 17, 2025, for the supply of Entyvio 300 mg vials. The award is a firm fixed-price delivery order with an ultimate completion date of October 8, 2025, and represents performance in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a $500M vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. No set-aside designation was used for this award.
Entyvio is a biologic medication used to treat inflammatory bowel diseases, and this order fulfills the Medical Supply Chain division of the Defense Logistics Agency's need for this specialized pharmaceutical product. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Department procurement markets. The company's extensive contract portfolio with the DLA demonstrates consistent performance in delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DX25F6XTP?
SPE2DX25F6XTP was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 17, 2025.
How much is contract SPE2DX25F6XTP worth?
The government has obligated $98,899 on SPE2DX25F6XTP.
Is contract SPE2DX25F6XTP an order under another contract?
Yes. SPE2DX25F6XTP is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTP competed?
The extent of competition for SPE2DX25F6XTP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award